ASLN Aslan Pharmaceuticals Ltd ADR
ASLN Stock Analysis Overview
What this means: InvestorsObserver gives Aslan Pharmaceuticals Ltd ADR (ASLN) an overall rank of 31, which is below average. Aslan Pharmaceuticals Ltd ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 31 means that 69% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
ASLN Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
ASLN Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
ASLN Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
ASLN Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
ASLN Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
ASLN Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
ASLN Stock Analysis Overview
What this means: InvestorsObserver gives Aslan Pharmaceuticals Ltd ADR (ASLN) an overall rank of 31, which is below average. Aslan Pharmaceuticals Ltd ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 31 means that 69% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.